Lipoprotein(a): The Inherited Cholesterol Number You've Probably Never Had Tested

Most people who watch their cholesterol have never heard of this one — and it may be the most important cholesterol number they're missing. Lipoprotein(a), written Lp(a) and said "L-P-little-a," is a cholesterol particle you inherit, that roughly one in five people carry at high levels, and that ordinary cholesterol tests don't include unless someone asks. It's also one of the more genuinely new areas of preventive cardiology, with the first drugs designed to lower it now in late-stage trials. This is a plain-language, current guide to what Lp(a) is, why it matters, and what a high result does and doesn't mean. It's general education, not a diagnosis; your own results are interpreted by a doctor who knows your history.

What is Lp(a)?

Lp(a) is a particle similar to LDL — the "bad" cholesterol — but with an extra protein, apolipoprotein(a), wrapped around it. Functionally it behaves like a stickier, more inflammatory cousin of LDL, and it contributes to the gradual furring-up of arteries known as atherosclerosis ¹.

The defining feature of Lp(a) is that its level is overwhelmingly genetic. The major heart associations put it plainly: somewhere between 70% and 90% of the difference in Lp(a) between people is determined by their genes ³. Your level is largely set by early childhood, stays roughly stable for the rest of your life, and — crucially — isn't meaningfully moved by diet or exercise ¹. That single fact drives almost everything else about how it's used.

Why it matters: an independent, inherited cause of heart disease

For years Lp(a) was a curiosity. What changed is the strength of the genetic evidence. Because your Lp(a) gene is fixed at conception and not confounded by lifestyle, researchers can use it almost like a natural experiment — and those studies show Lp(a) is not just associated with heart disease but a causal, independent risk factor for it ³. Specifically, a high Lp(a) raises the risk of:

• Heart attacks and coronary artery disease
• Strokes
• Narrowing of the aortic valve (aortic stenosis) — a link few other cholesterol markers share ⁴

"Independent" is the key word: Lp(a) adds risk on top of your LDL, blood pressure and the rest — so someone with picture-perfect standard cholesterol can still carry meaningful hidden risk from a high Lp(a) ⁵. And it's common: about 1 in 5 people (~20%) worldwide have an elevated level, making it the most prevalent inherited cholesterol disorder ².

What counts as high — and the units trap

Broadly ⁵:

• Below ~30 mg/dL is considered low risk.
• A grey zone sits between roughly 30 and 50 mg/dL.
• Above ~50 mg/dL (or ≥125 nmol/L) is considered high.

Two honest caveats. First, risk rises continuously — there's no magic cliff at the cut-off, so a value somewhat above 50 isn't a separate disease from one at 49 ⁴. Second, watch the units: Lp(a) is reported either in mg/dL (a measure of mass) or nmol/L (a measure of particle number), and the two are not interchangeable — converting between them is imprecise, so compare like with like and let the lab and doctor interpret which scale your result is on ⁴.

If statins don't lower it, what's the point of testing?

This is the question everyone asks, and it has a good answer. It's true that the usual tools barely touch Lp(a): diet and exercise don't change it, and statins don't lower it — they may even raise it by 10–20% ⁵. So testing isn't about getting a number to "treat" down. Its value is risk stratification — knowing your Lp(a) changes the plan in concrete ways ⁵:

• It reclassifies your overall heart risk, especially if your standard cholesterol looks fine but heart disease runs in the family.
• It raises the urgency of controlling everything you can change — LDL, blood pressure, smoking, blood sugar, weight — more aggressively.
• It flags blood relatives, who may share the inherited level and benefit from their own check.

That's why major guidelines — the 2022 European Atherosclerosis Society consensus among them — now recommend measuring Lp(a) at least once in a lifetime in adults ⁴. Once is usually enough precisely because it barely changes.

The latest science: drugs that target Lp(a)

Here's what's genuinely new. For the first time, therapies designed specifically to lower Lp(a) are in advanced trials — and they're potent. RNA-based drugs (with names like pelacarsen, olpasiran, zerlasiran and lepodisiran, plus an oral agent, muvalaplin) have been shown to cut Lp(a) by roughly 80–95% in early studies ⁵.

The essential caveat: lowering the number is not yet proven to lower heart attacks. Large "outcome" trials — for example pelacarsen's Lp(a)HORIZON and olpasiran's OCEAN(a) — are running now, with key results expected from around 2025–2026 onward ⁵. Until they report, no Lp(a)-specific drug is approved, and the established play remains the same: find out your level once, and if it's high, manage the rest of your risk harder. It's a field worth watching — but today the testing is for knowledge and strategy, not a new prescription.

What we see at the clinic

Lp(a) is one of the tests we're asked about most by the more health-engaged people who pass through Pattaya — often someone with a strong family history of early heart attacks whose standard cholesterol looks reassuringly normal, and who can't understand why. That's the classic Lp(a) story: a hidden, inherited risk that the usual panel never reveals. Because it's a once-in-a-lifetime test that barely changes, it's an easy, high-value add to a baseline for the right person. We're honest about what a high result means, though — it isn't a number we can medicate away today, and it isn't a verdict. What it does is sharpen the case for taking the standard cholesterol panel, blood pressure and the rest seriously, and for letting family members know they might want to check too. Interpreting it, and deciding what to do, is a conversation with a doctor.

Common questions

My regular cholesterol is normal — why would I have high Lp(a)? Because Lp(a) is a separate, inherited particle that standard cholesterol tests don't include, and it adds risk independently of your LDL ⁵. Someone with excellent routine cholesterol can still carry a high Lp(a) — which is exactly why it's measured separately.

Can I lower my Lp(a) with diet, exercise or a statin? Not meaningfully. Lp(a) is largely genetic and isn't moved by diet or exercise, and statins don't lower it (they may raise it slightly) ⁵. A high result is a reason to manage every other risk factor harder, not a target you lower directly — at least until the new drugs in trials are proven.

How often should I get it tested? Usually just once. Because your level is set by genetics and stays roughly stable for life, a single measurement in adulthood is generally enough ¹. Repeat testing is rarely needed unless a specific situation calls for it.

Does a high Lp(a) mean I'll definitely have a heart attack? No. It raises risk, it doesn't seal fate — it's one important factor among several ³. Its real use is to tell you and your doctor to be more aggressive about the risks you can control, and to alert your family.

Should my family get tested too? Often, yes. Because it's inherited, a high Lp(a) in you means close blood relatives may carry it as well, so it's reasonable for them to have their own one-time check ².

Key takeaway

Lp(a) is the inherited cholesterol number most people never have measured — an LDL-like particle that's 70–90% genetic, fixed for life, and an independent, causal contributor to heart attacks, strokes and aortic-valve disease, carried at high levels by about 1 in 5 people ³. Because diet, exercise and statins don't lower it, the point of testing isn't to treat the number down but to know it once and let it sharpen how hard you manage everything else — and to prompt family to check ⁵. Drugs that lower Lp(a) by 80–95% are in late-stage trials, but proof they prevent heart attacks is still pending ⁵. For anyone with a family history of early heart disease — or unexplained risk despite a normal cholesterol panel — a single Lp(a) test is one of the more worthwhile lines to add to a baseline.